Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Mar 3;2019:6357609. doi: 10.1155/2019/6357609

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2019 Joseph W. George et al.

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

BRCA2 mediates the cytotoxicity induced by gemcitabine. Impact of BRCA2 on the cellular sensitivity to gemcitabine was examined. BRCA2-deficient ovarian cancer cell line PE01 (closed square with dashed line) and pancreatic cancer cell line CAPAN1 (closed square with dashed line) are more resistant to gemcitabine compared to PE01(C4-2) (closed triangle) and CAPAN1 (C2-1) (closed triangle) that regain active BRCA2, respectively. Three independent experiments were performed and averages of surviving fraction are plotted. The error bars show standard deviations. The differences in the gemcitabine sensitivity between PE01 and PE01(C4-2), or CAPAN1 and CAPAN1(C2-1), are statistically significant with p<0.05.